Suzanne Crowe - 09 Dec 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Director
Signature
Nicole Kelsey, by power of attorney
Issuer symbol
RCEL
Transactions as of
09 Dec 2024
Net transactions value
+$6,391
Form type
4
Filing time
29 Jan 2025, 16:57:48 UTC
Previous filing
06 Jun 2024
Next filing
05 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Purchase $6,391 +486 +1.3% $13.15 36,912 09 Dec 2024 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects 2,430 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of the Issuer's common stock and have all the rights and privileges of common stock.
F2 The purchase price was converted from A$4.11, using the exchange rate as in effect on the date of the transaction, and reflects the 5:1 consolidation ratio applied in converting CDIs to shares of the Issuer's common stock.
F3 Includes 22,990 of the Issuer's CDIs. The Reporting Person's 22,990 CDIs translate into 4,598 of the shares of Common Stock set forth above.
F4 Includes unvested RSUs.